Cure My Disease

Don't miss your cure!

 Log in / Sign up

New burn treatment combo aims to speed healing

NCT ID NCT07367087

Symptom relief Sponsor: Dr Muhammad Naveed Shahzad Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding hyaluronic acid to a standard burn cream (silver sulfadiazine) helps second-degree burns heal faster. Thirty people with similar burns on both sides of their body will have one side treated with the combo and the other with standard cream alone. The main goal is to see which side heals quicker.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
silver sulfadiazine combined with hyaluronic acid
What this could lead to
If it works, this could lead to faster healing for partial-thickness burns with a simple addition to standard care.
What could go wrong
This is a very small early trial (30 people) and not yet recruiting. The benefit may be small or not seen at all, and results may not apply to larger burns.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria Patients with acute bilateral partial-thickness (second-degree) thermal burns where both sides/areas are comparable and suitable for intra-patient treatment (one area treated with SSD+HA and the contralateral area with SSD alone) Presentation within 72 hours of burn injury Small to moderate total burn surface area suitable for conservative topical management Burn wounds not requiring immediate excision or grafting at baseline Ability to comply with daily dressing application and follow-up until complete re-epithelialization Written informed consent from patient; for minors, parent/guardian consent and assent where applicable Exclusion Criteria Full-thickness (third-degree) burns or mixed-depth burns in the study areas Chemical, electrical, radiation, or inhalational burns requiring ICU or ventilatory support Infected burn wounds at baseline requiring systemic antibiotics Major comorbidities likely to impair wound healing (e.g., uncontrolled diabetes, severe peripheral vascular disease, immunosuppression, severe malnutrition) Known hypersensitivity to silver sulfadiazine, sulfonamides, hyaluronic acid, or formulation components Pregnancy or lactation (as per institutional policy) Non-comparable bilateral burn wounds Concurrent participation in another interventional wound or burn study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Partial-thickness burn, thermal burn are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Partial-thickness burn, thermal burn

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Nishtar Medical University & Hospital, Multan

    Multan, Punjab Province, 60000, Pakistan